Stem Cell Aging Leukemia and Lymphoma (SALL)

University of Groningen > Faculteit Medische Wetenschappen/UMCG > Cancer Research Center Groningen (CRCG) > Stem Cell Aging Leukemia and Lymphoma (SALL)

  1. 2020
  2. Hoff, F. W., van Dijk, A. D., Qiu, Y. H., Ruvolo, P. P., Gerbing, R. B., Leonti, A. R., Jenkins, G. N., Gamis, A. S., Aplenc, R., Kolb, E. A., Alonzo, T., Meshinchi, S., De Bont, E., Bruggeman, S. W., Kornblau, S. M., & Horton, T. M. (2020). Heat Shock Factor 1 (HSF1-pSer326) Predicts Response to Bortezomib-Containing Chemotherapy in Pediatric AML: A COG Study. Blood. https://doi.org/10.1182/blood.2020005208
  3. Wang, S., Lin, Y., Xiong, X., Wang, L., Guo, Y., Chen, Y., Chen, S., Wang, G., Lin, P., Chen, H., Yeung, S-C. J., Bremer, E., & Zhang, H. (2020). Low-dose metformin reprograms the tumor immune microenvironment in human esophageal cancer: Results of a phase II clinical trial. Clinical Cancer Research, F1-F12. https://doi.org/10.1158/1078-0432.CCR-20-0113
  4. Wester, R., Zweegman, S., van der Holt, B., Kersten, M. J., Vellenga, E., van Marwijk-Kooy, M., Asselbergs, E., de Weerdt, O., Minnema, M. C., Lonergan, S., Palumbo, A., Broijl, A., & Sonneveld, P. (2020). Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial. HemaSphere, 4(4), [e370]. https://doi.org/10.1097/HS9.0000000000000370
  5. Saba, K. H., Cornmark, L., Hofvander, J., Magnusson, L., Nilsson, J., van den Bos, H., Spierings, D. C., Foijer, F., Staaf, J., Brosjö, O., Sumathi, V. P., Lam, S. W., Szuhai, K., Bovée, J. V., Kovac, M., Baumhoer, D., Styring, E., & Nord, K. H. (2020). Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma. Journal of pathology clinical research, 6(4), 231-237. https://doi.org/10.1002/cjp2.172
  6. Cruijsen, M., van der Velden, W. J. F. M., de Haan, A. F. J., Klein, S. K., Hoogendoorn, M., Tromp, Y., de Valk, B., van Rees, B., de Boer, F., van der Spek, E., Pruijt, J., Verdonck, L. F., Vellenga, E., Blijlevens, N., van de Loosdrecht, A. A., & Huls, G. (2020). Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study. Leukemia & Lymphoma, (11), 1-4. https://doi.org/10.1080/10428194.2020.1775217
  7. Niu, F., Kazimierska, M., Nolte, I. M., Terpstra, M. M., de Jong, D., Koerts, J., van der Sluis, T., Rutgers, B., O'Connell, R. M., Kok, K., van den Berg, A., Dzikiewicz-Krawczyk, A., & Kluiver, J. (2020). The miR-26b-5p/KPNA2 Axis Is an Important Regulator of Burkitt Lymphoma Cell Growth. Cancers, 12(6), 1-20. [1464]. https://doi.org/10.3390/cancers12061464
  8. Höppener, D. J., Nierop, P. M. H., Hof, J., Sideras, K., Zhou, G., Visser, L., Gouw, A. S. H., de Jong, K. P., Sprengers, D., Kwekkeboom, J., Vermeulen, P. B., Grünhagen, D. J., & Verhoef, C. (2020). Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis. British Journal of Cancer, 123(2), 196-206. https://doi.org/10.1038/s41416-020-0881-z
  9. Kersten, M. J., Driessen, J., Zijlstra, J. M., Plattel, W. J., Morschhauser, F., Lugtenburg, P. J., Brice, P., Hutchings, M., Gastinne, T., Liu, R., Burggraaff, C. N., Nijland, M., Tonino, S. H., Arens, A. I. J., Valkema, R., van Tinteren, H., Lopez-Yurda, M., Diepstra, A., De Jong, D., & Hagenbeek, A. (2020). Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study. Haematologica. https://doi.org/10.3324/haematol.2019.243238
  10. Hof, J., Visser, L., Höppener, D. J., Nierop, P. M. H., Terpstra, M. M., Gouw, A. S. H., Grünhagen, D. J., Verhoef, C., Sijmons, R. H., de Jong, K. P., & Kok, K. (2020). B Cells as Prognostic Biomarker After Surgery for Colorectal Liver Metastases. Frontiers in Oncology, 10, [249]. https://doi.org/10.3389/fonc.2020.00249
  11. Wudarski, J., Egger, B., Ramm, S. A., Schärer, L., Ladurner, P., Zadesenets, K. S., Rubtsov, N. B., Mouton, S., & Berezikov, E. (2020). The free-living flatworm Macrostomum lignano. EvoDevo, 11(1), [5]. https://doi.org/10.1186/s13227-020-00150-1
  12. Lähnemann, D., Köster, J., Szczurek, E., McCarthy, D. J., Hicks, S. C., Robinson, M. D., Vallejos, C. A., Campbell, K. R., Beerenwinkel, N., Mahfouz, A., Pinello, L., Skums, P., Stamatakis, A., Attolini, C. S-O., Aparicio, S., Baaijens, J., Balvert, M., Barbanson, B. D., Cappuccio, A., ... Schönhuth, A. (2020). Eleven grand challenges in single-cell data science. Genome Biology, 21(1), 31-35. [31]. https://doi.org/10.1186/s13059-020-1926-6
  13. Dutch-Belgian Hemato-Oncology, Swiss Grp Clinical Canc Res SAKK, Ossenkoppele, G. J., Breems, D. A., Stuessi, G., Van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B. T., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., ... Lowenberg, B. (2020). Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS. Leukemia, (7), 1751-1759. https://doi.org/10.1038/s41375-020-0725-0
  14. Morello, L., Rattotti, S., Giordano, L., Jerkeman, M., van Meerten, T., Krawczyk, K., Moita, F., Marino, D., Ferrero, S., Szymczyk, M., Aurer, I., El-Galaly, T. C., Di Rocco, A., Visco, C., Carli, G., Defrancesco, I., Carlo-Stella, C., Dreyling, M., Santoro, A., & Arcaini, L. (2020). Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study. HemaSphere, 4(1), [302]. https://doi.org/10.1097/HS9.0000000000000302
Previous 1 2 3 4 5 6 7 8 ...36 Next

ID: 37366